Hunan Jingfeng Pharmaceutical: Notice on holding the first bondholder meeting of the "16 Jingfeng 01" bonds in 2024.
Hunan Jingfeng Pharmaceutical: Hunan Jingfeng Pharmaceutical Co., Ltd.'s entrusted management report on the public issuance of corporate bonds (first phase) for qualified investors in 2016 (2023).
Jingfeng Pharmaceutical: Notice on holding the first bondholders\' meeting on 16 Jingfeng 01 2023
Jingfeng Pharmaceutical: Jingfeng Pharmaceutical: 2016 Public Issuance of Corporate Bonds to Qualified Investors (Phase 1) Fiduciary Management Report (2022)
Jingfeng Pharmaceutical: Hunan Jingfeng Pharmaceutical Co., Ltd. 2023 Annual Follow-up Rating Report
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
Jingfeng Pharmaceutical: The company's announcement on partial payment of “16 Jingfeng 01” principal
Jingfeng Pharmaceutical: The company's announcement on partial payment of “16 Jingfeng 01” principal
Jingfeng Pharmaceutical: The company's announcement on partial payment of “16 Jingfeng 01” principal
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
Jingfeng Pharmaceutical: Jingfeng Pharmaceutical: 2016 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) Trust Management Report (2021)
Jingfeng Pharmaceutical: Announcement on adjustments to credit ratings of entities and bonds
Jingfeng Pharmaceutical: Hunan Jingfeng Pharmaceutical Co., Ltd. publicly issued corporate bonds to qualified investors in 2016 (first phase) 2022 tracking rating report
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
Jingfeng Pharmaceutical: Announcement on “16 Jingfeng 01” to change credit enhancement measures
Jingfeng Pharmaceutical: Announcement on preparing for asset impairment and loss
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
Jingfeng Pharmaceutical: The company's announcement on partial payment of “16 Jingfeng 01” principal
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
No Data